IL233290A0 - Preparation composition, and use of dense chitosan membrane materials - Google Patents

Preparation composition, and use of dense chitosan membrane materials

Info

Publication number
IL233290A0
IL233290A0 IL233290A IL23329014A IL233290A0 IL 233290 A0 IL233290 A0 IL 233290A0 IL 233290 A IL233290 A IL 233290A IL 23329014 A IL23329014 A IL 23329014A IL 233290 A0 IL233290 A0 IL 233290A0
Authority
IL
Israel
Prior art keywords
preparation
composition
membrane materials
chitosan membrane
dense chitosan
Prior art date
Application number
IL233290A
Other languages
English (en)
Hebrew (he)
Original Assignee
Agenta Biotechnologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agenta Biotechnologies Inc filed Critical Agenta Biotechnologies Inc
Publication of IL233290A0 publication Critical patent/IL233290A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
    • C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
    • C08J3/075—Macromolecular gels
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2305/00—Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00
    • C08J2305/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Dispersion Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL233290A 2011-12-22 2014-06-22 Preparation composition, and use of dense chitosan membrane materials IL233290A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161579003P 2011-12-22 2011-12-22
PCT/US2012/070617 WO2013096448A1 (en) 2011-12-22 2012-12-19 Composition, preparation, and use of dense chitosan membrane materials

Publications (1)

Publication Number Publication Date
IL233290A0 true IL233290A0 (en) 2014-08-31

Family

ID=48669446

Family Applications (1)

Application Number Title Priority Date Filing Date
IL233290A IL233290A0 (en) 2011-12-22 2014-06-22 Preparation composition, and use of dense chitosan membrane materials

Country Status (7)

Country Link
EP (1) EP2793908A4 (ja)
JP (1) JP2015511214A (ja)
KR (1) KR20140122231A (ja)
CN (1) CN104144692A (ja)
BR (1) BR112014015444A2 (ja)
IL (1) IL233290A0 (ja)
WO (1) WO2013096448A1 (ja)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103893204B (zh) * 2014-04-03 2016-05-11 石家庄亿生堂医用品有限公司 一种壳聚糖盐酸盐钙止血粉的制备方法
WO2017099261A1 (ko) * 2015-12-07 2017-06-15 주식회사 글로원 염침출 및 침지침강법을 이용한 스캐폴더 제조방법 및 그 스캐폴더
WO2017122216A1 (en) * 2016-01-14 2017-07-20 Amnivor Medicare Private Limited A process for extraction of collagen from fish scale and polyelectrolyte based bioactive super-absorbent materials
CN109627463B (zh) * 2016-06-22 2022-04-01 深圳普洛美康材料有限公司 水凝胶与蛋白质药物
US11491107B2 (en) * 2016-11-04 2022-11-08 Axio Biosolutions Pvt. Ltd. Mucoadhesive preparations, methods and applications thereof
WO2019051750A1 (zh) * 2017-09-14 2019-03-21 谭玲 一种聚乙二醇改性壳聚糖膜的制备方法
ES2906715T3 (es) * 2018-09-06 2022-04-20 Marine Essence Biosciences Corp Of Usa Dispositivos de biomaterial para la regeneración de tejidos guiada
KR102205564B1 (ko) * 2019-03-08 2021-01-22 주식회사 제론바이오 Pdrn이 캡슐화된 키토산 나노 입자가 포함된 키토산 나노필름 및 이의 제조 방법
CN111234289B (zh) * 2020-02-11 2022-04-01 南通大学 一种防粘连聚甲醛结扎止血夹及其制备方法与应用
KR102256257B1 (ko) * 2020-04-21 2021-05-26 한국화학연구원 키랄상의 질소-도핑된 네마틱 탄소-쉬스 나노섬유, 이의 제조방법, 및 이의 용도
CN114306714B (zh) * 2021-12-31 2022-08-02 安徽科门生物科技有限公司 一种制备用于皮肤再生修复的干细胞复合生物材料的方法
CN115252879A (zh) * 2022-07-13 2022-11-01 肖地生 一种壳聚糖止血材料的制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020131933A1 (en) * 1996-01-16 2002-09-19 Yves Delmotte Biopolymer membrane and methods for its preparation
US6271278B1 (en) * 1997-05-13 2001-08-07 Purdue Research Foundation Hydrogel composites and superporous hydrogel composites having fast swelling, high mechanical strength, and superabsorbent properties
US6740752B2 (en) * 2000-05-12 2004-05-25 The Procter & Gamble Company Process for preparing chitosan particles
US7371403B2 (en) * 2002-06-14 2008-05-13 Providence Health System-Oregon Wound dressing and method for controlling severe, life-threatening bleeding
US7536962B2 (en) * 2005-04-19 2009-05-26 Kamterter Ii, L.L.C. Systems for the control and use of fluids and particles

Also Published As

Publication number Publication date
JP2015511214A (ja) 2015-04-16
EP2793908A4 (en) 2015-08-19
CN104144692A (zh) 2014-11-12
WO2013096448A1 (en) 2013-06-27
KR20140122231A (ko) 2014-10-17
BR112014015444A2 (pt) 2017-07-04
EP2793908A1 (en) 2014-10-29

Similar Documents

Publication Publication Date Title
IL233290A0 (en) Preparation composition, and use of dense chitosan membrane materials
IL250824B (en) Certain amino-pyrimidines, their assemblies, and methods of using them
ZA201309669B (en) Immunoconjugates,composition containing them,and methods of making and use
ZA201209739B (en) Levocarrimycin,pharmaceutical compositions,preparation methods and uses thereof
EP2702054A4 (en) NOVEL BISAMINOQUINOLINE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS PREPARED THEREFROM, AND USE THEREOF
HK1202415A1 (en) Pharmaceutical compositions comprising dgla, 15-ohepa, and/or 15- hetre and methods of use thereof dgla15-ohepa/ 15-hetre
EP2530079A4 (en) PHENYL-C-GLUCOSIDE DERIVATIVES, PREPARATION METHODS AND USES THEREOF
EP2688688A4 (en) AQUEOUS CLEANING COMPOSITION WITHOUT NITROGEN, PREPARATION AND USE THEREOF
EP2718331A4 (en) N, N, N-TRIALKYL POLYMERS, METHODS FOR THEIR PREPARATION, AND USES THEREOF
EP2621966A4 (en) ELASTIC WATER VAPOR PERMEABLE FILMS AND THEIR PREPARATION AND USE
EP2550954A4 (en) VASELINE-TYPE COMPOSITION AND COSMETIC PREPARATION
HK1182934A1 (zh) 種抗疲勞的組合物及其製劑和應用
ZA201207178B (en) Oxadiazole compounds,their preparation and use
PT2687539T (pt) Variante de anexina v sua preparação e utilização
EP2742020A4 (en) N1-CYCLIC AMIN-N5-SUBSTITUTED BIGUANIDE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITION THEREWITH
EP2766375A4 (en) PREPARATION OF NEW FLUORIN COMPOUNDS, METHOD OF MANUFACTURING AND COMPOSITIONS MADE THEREOF
EP2671878A4 (en) SUBSTITUTED N-PENTANAMIDE COMPOUNDS, PREPARATION METHODS AND USES THEREOF
EP2757092A4 (en) SUBSTITUTED CYANANILIN COMPOUNDS, METHOD OF MANUFACTURING THEREOF AND USE THEREOF
IL221730A0 (en) Derivatives of aminoindanes, their preparation and their application in therapeutics
EP2903979A4 (en) Novel compounds, their preparation and use
EP2738159A4 (en) MERCAPTO-BENZOPHENONE COMPOUNDS, COMPOSITIONS AND METHODS OF PREPARATION THEREOF
EP2525900A4 (en) NITROGEN PERMANENT MEMBRANES AND USES THEREOF
EP2766183A4 (en) IRON FIBER COMPOSITION, PREPARATION THEREOF AND USES THEREOF
EP2701689A4 (en) PHARMACEUTICAL COMPOSITIONS OF RALTEEGRAVIR, METHODS OF PREPARATION AND USE THEREOF
HK1199374A1 (en) Shirring composition and uses thereof